Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Hanmi Science (008930 KS)
Watchlist
70
Analysis
Health Care
•
South Korea
Hanmi Science Co., Ltd. produces pharmaceutical products, including antibiotics, vitamins, and intestinal tonics. The Company also provides beverages and processes soft capsules for other pharmaceutical firms.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
Hanmi Science
•
07 Aug 2026 22:00
Primer: Hanmi Science (008930 KS) - Aug 2026
Hanmi Science operates as the holding company for the Hanmi Pharmaceutical Group, with its valuation and performance intrinsically linked to...
αSK Primers
98 Views
Share
bullish
•
Quantitative Analysis
•
24 Jan 2024 06:58
Using Smartkarma's Smart Score Screener to Screen Alpha Generating Stocks in Korea
In this insight, we discuss using Smartkarma's new feature called Smart Score Screener to screen alpha generating stocks in Korea.
Douglas Kim
Follow
766 Views
Share
bullish
•
Thematic (Sector/Industry)
•
26 Jul 2026 08:30
APAC Healthcare Weekly (July 26) – Hengrui, BeOne, Takeda, Nippon Shinyaku, Samsung Bio, Celltrion
Hengrui’s camrelizumab got indication expansion approval for cervical cancer. BeOne announced $300M expansion plan for US facility. Samsung...
Tina Banerjee
Follow
132 Views
Share
bullish
•
Thematic (Sector/Industry)
•
10 Apr 2026 21:35
The Stocks to Own in Asia – Vol. 52
We highlight 14 stocks in Asia that look interesting to us based on our FVMR methodology. Portfolio changes: Five stocks remain, nine new join the...
A. Stotz Investment Research
Follow
244 Views
Share
bullish
•
Samsung C&T
•
01 Oct 2026 07:51
Korean Holdcos Vs Opcos Gap Trading Opportunities in 4Q 2026
In this insight, I highlight the recent pricing gap divergences of the major Korean holdcos and opcos which could provide trading opportunities in...
Douglas Kim
Follow
146 Views
Share
1
2
3
4
Next
Last
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.4
x